Stay updated on Cyclophosphamide vs Abatacept After Stem Cell Transplant Clinical Trial
Sign up to get notified when there's something new on the Cyclophosphamide vs Abatacept After Stem Cell Transplant Clinical Trial page.

Latest updates to the Cyclophosphamide vs Abatacept After Stem Cell Transplant Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry v3.3.2 was added to the record history, and revision v3.2.0 was removed.SummaryDifference0.1%

- Check36 days agoChange DetectedRemoved the site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check51 days agoChange DetectedNew entries were added to the Study Record History (versions 12 and 13) with updated submission dates; there are no changes to the study content, status, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedUpdated operating status notices and a newer revision/version, plus a current date and recruitment status. Older status and revision were removed.SummaryDifference14%

- Check86 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes.SummaryDifference0.3%

Stay in the know with updates to Cyclophosphamide vs Abatacept After Stem Cell Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cyclophosphamide vs Abatacept After Stem Cell Transplant Clinical Trial page.